Medigraph Pharmaceuticals is an API manufacturer based in India. It holds one valid CEP across a filed portfolio of 3 molecules. Its GMP standing is certified by EMA. Customs aggregates show $6.6M of exports covering 81 molecules to 30 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Taloja, India | Not on file |
| Mumbai, India | Not on file |
| M. 1. 0. C. Taloja, Dist. Raigad, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Bupivacaine | EDQM | 1 |
| Meperidine | SFDA (Saudi Arabia) | 1 |
| Olopatadine | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $163K | 6 |
| 2025 | Not reported | $6.6M | 30 |
| 2024 | Not reported | $703K | 29 |
| 2023 | Not reported | $1.4M | 29 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Medigraph Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free